Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/112644
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease |
Autor: | Canals, Josep María; Pineda, José Ramón; Torres-Peraza, Jesús F. CSIC; Bosch, Miquel; Martín-Ibáñez, Raquel; Muñoz, María Teresa; Mengod Los Arcos, Guadalupe CSIC ORCID; Ernfors, Patrik; Alberch, Jordi CSIC | Palabras clave: | PolyQ Striatum Neurotrophins Movement disorders Knock-out Cell death |
Fecha de publicación: | 1-sep-2004 | Editor: | Society for Neuroscience | Citación: | Journal of Neuroscience 24(35): 7727-7739 (2004) | Resumen: | The mechanism that controls the selective vulnerability of striatal neurons in Huntington's disease is unclear. Brain-derived neurotrophic factor (BDNF) protects striatal neurons and is regulated by Huntingtin through the interaction with the neuron-restrictive silencer factor. Here, we demonstrate that the downregulation of BDNF by mutant Huntingtin depends on the length and levels of expression of the CAG repeats in cell cultures. To analyze the functional effects of these changes in BDNF in Huntington's disease, we disrupted the expression of bdnf in a transgenic mouse model by cross-mating bdnf(+/ -) mice with R6/1 mice. Thus, we compared transgenic mice for mutant Huntingtin with different levels of BDNF. Using this double mutant mouse line, we show that the deficit of endogenous BDNF modulates the pathology of Huntington's disease. The decreased levels of this neurotrophin advance the onset of motor dysfunctions and produce more severe uncoordinated movements. This behavioral pathology correlates with the loss of striatal dopamine and cAMP-regulated phosphoprotein-32-positive projection neurons. In particular, the insufficient levels of BDNF cause specific degeneration of the enkephalinergic striatal projection neurons, which are the most affected cells in Huntington's disease. This neuronal dysfunction can specifically be restored by administration of exogenous BDNF. Therefore, the decrease in BDNF levels plays a key role in the specific pathology observed in Huntington's disease by inducing dysfunction of striatal enkephalinergic neurons that produce severe motor dysfunctions. Hence, administration of exogenous BDNF may delay or stop illness progression. | Versión del editor: | http://dx.doi.org/10.1523/JNEUROSCI.1197-04.2004 | URI: | http://hdl.handle.net/10261/112644 | DOI: | 10.1523/JNEUROSCI.1197-04.2004 | Identificadores: | doi: 10.1523/JNEUROSCI.1197-04.2004 issn: 0270-6474 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Canals-J-Neuroscience-2004-v24-n35-p7727.pdf | 990,75 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
129
checked on 17-abr-2024
SCOPUSTM
Citations
292
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
271
checked on 28-feb-2024
Page view(s)
291
checked on 22-abr-2024
Download(s)
290
checked on 22-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.